Appetite News and Research

RSS

Study: Oatmeal breakfast shows greater increase in appetite control than ready-to-eat cereal

While obesity is a complex and multifaceted problem, much of the strategy behind combating it boils down to healthy eating habits. Taking into account the primary role of subjective appetite sensations in said habits, a group of researchers recently compared the satiety impact of two popular breakfast choices: oatmeal and ready-to-eat breakfast cereal (RTEC).

25 Nov 2013

Transarterial embolization procedure helps reduce body weight

A new study reports that individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9 percent decrease in body weight three months after the procedure. Results of the study, which offer a potential new avenue for obesity research, will be presented next week at the annual meeting of the Radiological Society of North America.

25 Nov 2013

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Bayer HealthCare and Onyx Pharmaceuticals, Inc., an Amgen subsidiary, today announced that the U.S. Food and Drug Administration has approved a supplemental New Drug Application for the oral multi-kinase inhibitor NEXAVAR (sorafenib) tablets for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment.

23 Nov 2013

Study reveals how obesity alters our relationship to food

Obesity may alter the way we taste at the most fundamental level: by changing how our tongues react to different foods.

22 Nov 2013

Research shows superiority of whey protein

As science continues to support the role of protein in building and maintaining lean muscle, maintaining weight and aging healthy, consumers are embracing the important role of protein in the diet. But not all proteins are created equal and it turns out that protein quality really does matter.

16 Nov 2013

SNAP may not be enough to provide beneficiaries with long-term food security or dietary quality

Millions of families in the United States struggle to provide nutritionally adequate meals due to insufficient money or other resources. To combat food security issues, over one in seven Americans currently rely upon the Supplemental Nutrition Assistance Program (SNAP), the largest federal nutrition program, to provide monetary support for nutrition. In the past, SNAP has been shown to reduce poverty among the poorest Americans and generate economic activity.

16 Nov 2013

Zafgen presents safety, efficacy data from beloranib Phase 2 study at Obesity Week 2013

Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.

15 Nov 2013

Eating protein-rich breakfast improves appetite control throughout the morning

While Americans generally consume enough protein, they tend to eat a small amount at breakfast, moderate amounts at lunch, and the largest amount at dinner. New research presented today at The Obesity Society's annual scientific meeting in Atlanta shows that eating high protein sausage and egg-based breakfasts curbed hunger throughout the morning, compared with a low-protein breakfast (pancakes and syrup) or skipping breakfast, in 18-55-year-old women.

15 Nov 2013

Imbruvica gets FDA approval for treatment of mantle cell lymphoma

The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma, a rare and aggressive type of blood cancer.

13 Nov 2013

Obesity, bipolarity may have common mechanisms

The presence of obesity in patients with major depression could be a sign of underlying bipolarity, say researchers.

12 Nov 2013

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Swiss-based Helsinn group has granted Chugai Pharma Marketing Ltd., a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd., exclusive commercialization rights to their innovative ghrelin receptor agonist, anamorelin, for the three major European pharma markets.

12 Nov 2013

Diets and the famine reaction: an interview with Associate Professor Amanda Salis, University of Sydney

The statistic that you often hear is that 95% of diets fail, but in actual fact, emerging research is now showing that it’s around 70% of diets that fail. That means that around 30% of people who are losing weight are actually keeping it off. So we’re doing better now than we were doing in the past, but there’s still work to be done.

7 Nov 2013

New treatment option for patients with most difficult-to-treat forms of hepatitis C

A novel single-pill combination drug could present a new treatment option for patients with the most difficult-to-treat forms of hepatitis C, according to the results of a Phase 2 trial, published in The Lancet.

6 Nov 2013

Weight loss surgery: The most effective weapon for obese people in the battle against diabetes

Noted bariatric surgeon Michael Feiz, M.D., F.A.C.S., believes that there's no time like American Diabetes Month to point out that weight loss surgery is the most effective weapon obese people have in the battle against diabetes.

5 Nov 2013

Study examines impact of sleep on children's eating behaviors

It seems everyone is looking for a culprit when it comes to childhood obesity: fast food, sugary drinks, super-sized everything. But it turns out part of the blame may lie with the simple matter of turning out the lights and rolling into bed.

4 Nov 2013

New therapeutic approach for treating type 2 diabetes

Scientists from the Helmholtz Zentrum München (HMGU) and the Technische Universität München (TUM), together with scientists in the USA, have developed a new therapeutic approach for treatment of type 2 diabetes.

31 Oct 2013

Meal replacements and high protein diet can help weight loss maintenance

New research shows that there are several effective strategies available to people wanting to avoid regaining weight after a successful diet. Anti-obesity drugs, meal replacements and a high protein diet can help weight loss maintenance, according to a meta-analysis published in the scientific periodical The American Journal of Clinical Nutrition.

31 Oct 2013

Researchers highlight presence of specific antibodies that regulate appetite in obese patients

Obesity affects more than 15% of adults in France, and its constitutive mechanisms are still not completely explained. Normally, fine control of weight and food intake is coordinated by a specialised part of the brain (the hypothalamus).

31 Oct 2013

Scientists develop new therapeutic approach for treatment of type 2 diabetes

Scientists from the Helmholtz Zentrum Muenchen and the Technische Universitaet Muenchen, together with scientists in the USA, have developed a new therapeutic approach for treatment of Type 2 diabetes. A novel single molecule hormone, which acts equally on the receptors of the insulin-stimulating hormones GLP-1 and GIP, was observed to reduce weight and improve blood sugar.

31 Oct 2013

Inaugural "Leadership" award presented to co-founder of Anytime Fitness

Chuck Runyon, CEO and co-founder of Anytime Fitness, the world's fastest-growing gym, has been presented with an inaugural "Leadership" award by Chief Executive magazine.

30 Oct 2013

Appetite News and Research

Study: Oatmeal breakfast shows greater increase in appetite control than ready-to-eat cereal

Transarterial embolization procedure helps reduce body weight

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Study reveals how obesity alters our relationship to food

Research shows superiority of whey protein

SNAP may not be enough to provide beneficiaries with long-term food security or dietary quality

Zafgen presents safety, efficacy data from beloranib Phase 2 study at Obesity Week 2013

Eating protein-rich breakfast improves appetite control throughout the morning

Imbruvica gets FDA approval for treatment of mantle cell lymphoma

Obesity, bipolarity may have common mechanisms

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Diets and the famine reaction: an interview with Associate Professor Amanda Salis, University of Sydney

New treatment option for patients with most difficult-to-treat forms of hepatitis C

Weight loss surgery: The most effective weapon for obese people in the battle against diabetes

Study examines impact of sleep on children's eating behaviors

New therapeutic approach for treating type 2 diabetes

Meal replacements and high protein diet can help weight loss maintenance

Researchers highlight presence of specific antibodies that regulate appetite in obese patients

Scientists develop new therapeutic approach for treatment of type 2 diabetes

Inaugural "Leadership" award presented to co-founder of Anytime Fitness

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News